Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$111,699,485
-$15,259,826 QoQ
Shares Held
4,638,683
+2.6% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#94
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $2,915,385,555 across 19 Drug Manufacturers - General names. PFE ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
746,099 | $894,893,598 | |
| 2 | JNJ |
Johnson & Johnson
|
1,814,780 | $460,899,675 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,548,737 | $327,512,704 | |
| 4 | AZN |
Astrazeneca PLC
|
1,670,876 | $316,831,506 | |
| 5 | NVS |
Novartis AG
|
1,974,043 | $309,372,018 | |
| 6 | ABBV |
AbbVie Inc.
|
988,813 | $248,824,903 | |
| 7 | PFE |
Pfizer Inc
This page
|
4,638,683 | $111,699,485 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
502,809 | $63,524,888 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,699,485 | 4,638,683 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $126,959,311 | 4,521,343 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89,222,401 | 3,583,229 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $84,469,052 | 3,315,112 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $73,147,932 | 3,017,654 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $63,760,786 | 2,516,211 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $48,442,505 | 1,825,952 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $38,781,249 | 1,340,057 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,932,307 | 712,377 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,314,172 | 443,754 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,036,884 | 348,624 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,563,966 | 378,775 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,645,070 | 372,003 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $15,155,486 | 371,458 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $18,595,917 | 362,918 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,725,637 | 359,361 | Shares | Defined | 2022-11-03 | |
| 2022-06-30 | $19,201,647 | 366,234 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $19,296,232 | 372,730 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $22,741,985 | 385,131 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $15,795,852 | 367,260 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $14,401,637 | 367,764 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $12,981,135 | 358,298 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $12,931,095 | 351,293 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $12,425,909 | 338,581 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $10,672,865 | 326,387 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $11,280,433 | 345,602 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||